ACUPHARMA ApS: Financial statements 2020
CVR: 10072956
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,367,554 and a net result of DKK -234,576 compared with DKK 32,839 the year before. That is a decrease of 18.8% compared with the year before. Equity in the 2020 report amounted to DKK 152,230. The solvency ratio was 6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,367,554
- Profit/Loss
- DKK -234,576
- Equity
- DKK 152,230
- Total Assets
- DKK 2,550,285
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.4 mio. | -235 t. | 152 t. | 3 |
| 2019 | - | 1.7 mio. | 33 t. | 387 t. | 4 |
| 2018 | - | 1.7 mio. | 5 t. | 154 t. | - |
| 2017 | - | 1.5 mio. | 80 t. | 149 t. | - |
| 2016 | - | 1.1 mio. | 105 | 68 t. | - |
How creditworthy is ACUPHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ACUPHARMA ApS has published its annual report for 2019. Gross profit came to DKK 1,684,289, and the net result was DKK 32,839.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.